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Connexins and connexin channels play important
roles in cell growth/differentiation and tumorigenesis.
Here, we identified a relationship between a connexin
molecule and a critical cell-cycle regulator. Our data
show that connexin (Cx) 50 regulated lens cell-cycle
progression anddifferentiation bymodulating expres-
sion of cyclin-dependent kinase inhibitor p27/p57 and
E3 ubiquitin ligase Skp2. Cx50 directly interacted with
and retained Skp2 in the cytosol by masking the nu-
clear targeting domain of Skp2, and this effect was
supported by an increased nuclear localization of
Skp2, disruption of Skp2 interaction with importin-7,
and decreased levels of p27/p57 in mouse lenses
lackingCx50. As a result, Cx50 increased auto-ubiqui-
tination andsubsequent degradationofSkp2. Amuta-
tion (V362E) on the C terminus of Cx50 disrupted the
interaction between Cx50 and Skp2 and completely
abolished such effects. Therefore, this study identifies
a role for connexins in regulating cell-cycle modula-
tors and, consequently, cell growth and differentia-
tion.
INTRODUCTION
Connexins are membrane proteins that are the structural com-
ponents of both gap junctions and hemichannels (Goodenough
et al., 1996; Goodenough and Paul, 2003). These channels are
crucial in maintaining normal cell and tissue functions. Besides
forming gap junction channels and hemichannels, increasing
studies suggest a gap junction and hemichannel-independent
role of connexins in cell growth, differentiation, and tumorige-
nicity (Jiang and Gu, 2005; Jiang, 2010; Zhou and Jiang, 2014).
However, the molecular mechanisms underlying the function of
connexins in cell growth control and differentiation remain
largely unknown.
The eye lens is a unique organ representing various develop-
mental stages of cells with an enriched gap junction communica-
tion network (Lovicu and McAvoy, 2005; Wride, 1996). The
mature lens is composed of twomajor compartmental cell popu-
lations: mitotically active epithelial cells at the anterior part and
elongated fiber cells differentiated from epithelial cells at theDevelopmelens bow region, forming the bulk of the lens body (Tholozan
and Quinlan, 2007). The epithelial cells in the lens bow region
close to the lens equator withdraw themselves from the cell cycle
to initiate fiber cell differentiation, which is coordinated by the
cell-cycle CDK inhibitors p27 and p57 (Zhang et al., 1998; Rowan
et al., 2008). In p27/p57double knockout (KO)mice, lensdifferen-
tiation was found to be disrupted; however, enhanced prolifera-
tion was observed (Zhang et al., 1998). Ubiquitin-dependent pro-
teolysis via E3 ubiquitin ligase S-phase kinase protein 2 (Skp2) is
reported to be primarily responsible for p27 degradation (Pagano
et al., 1995; Carrano et al., 1999). The function of Skp2/p27 in cell
proliferation has been reported to be influenced by the presence
of Cx43 in mouse embryonic fibroblasts (Zhang et al., 2003b).
Three connexins, Cx43, Cx46, and Cx50 are abundantly ex-
pressed in the lens. Mice lacking genes encoding either Cx46
or Cx50 develop lens cataracts (Gong et al., 1997; White et al.,
1998; Rong et al., 2002); however, only Cx50-deficient mice
develop smaller lenses (White et al., 1998; Rong et al., 2002). In
Cx50 KO mouse lenses, reduced cell proliferation and delayed
denuclearization have also been reported (Sellitto et al., 2004;
Rong et al., 2002; Dunia et al., 2006), suggesting that Cx50 plays
an important role in cell proliferation.Our earlier studies show that
Cx50 is able to promote lens epithelial-fiber differentiation in lens
primary cell culture (Gu et al., 2003), a system that closely mimics
the differentiation process of lens cells in vivo (Menko et al., 1984;
Berthoud et al., 1999). Furthermore, this function is independent
of the role of Cx50 in forming gap junctions and hemichannels
(Banks et al., 2007, 2009). The intracellular C terminus (CT) of
Cx50 is sufficient to promote lens fiber cell differentiation. More-
over, the Val-362 (V362) residue within the CT domain, by main-
taining an a-helical structure, functionally participates in lens
epithelial-fiber differentiation (Shi et al., 2010).
In this study, we identified a mechanism of Cx50 in regulating
lenscell proliferationanddifferentiation through thedirect interac-
tion and cytoplasmic retention of the cell-cycle regulator, Skp2
and consequently, the enhanced stability of cell-cycle inhibitor
p27/p57. This mechanistic study establishes a direct functional
relationship between connexins and key cell-cycle regulators.RESULTS
The Stimulatory Role of Cx50 in LensCell Differentiation
Is Mediated by p27
To determine if lens cell differentiation is coupled to cell-cycle
regulation, we examined the expression of a CDK inhibitor, p27ntal Cell 35, 483–496, November 23, 2015 ª2015 Elsevier Inc. 483
Figure 1. The Stimulatory Effect of Cx50 on Lens Cell Differentiation Is Mediated by the Increased p27 Protein Level
(A) p27 protein expression increases associated with the enhancement of cell differentiation by Cx50 in chick lens primary cells.
(B) p27 localizes in the nuclei of lentoids in lens primary cell culture. Scale bar represents 20 mm.
(C) Knocking down p27 significantly attenuated the stimulatory effect of Cx50 on cell differentiation of primary lens cells. The differentiation level was assessed by
quantifying lentoid formation (middle). The AQP0 level was quantified by fluorescence area immunolabeled with anti-AQP0 antibody versus total area and
normalized to RCAS(A) vehicle group (right).
(D) Overexpression of p27 and p27(T187A) promotes the lens cell differentiation in chick lens primary cells. Cell lysates at the culturing day 8 were immunoblotted
with anti-Cx50, p27, or b-actin antibody (left). The lentoid formation was quantified during 3–8 days of culturing (middle). The AQP0 level was quantified by
fluorescence area immunolabeledwith anti-AQP0 antibody (right). All datawere presented as themeans ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001, compared
to vehicle control group, unless indicated otherwise.
See also Figure S1.using chick lens primary culture. At the fourth to fifth day of
culturing, lens epithelial cells clustered together to form a
crown-like structure, named ‘‘lentoids,’’ with characteristics
mimicking lens cell differentiation in vivo (Menko et al., 1984;
Jiang et al., 1993). The expression level of p27 was elevated at
the sixth day of culturing, along with the increased expression
level of lens differentiation markers, CP49 and Cx50 (Figure 1A).
We have previously showed that Cx50 promotes lens cell differ-
entiation (Gu et al., 2003). Here, we found that the level of p27
was further enhanced in primary lens cells overexpressing exog-
enous Cx50, indicated by the higher level of total Cx50 protein as
compared to vehicle control cells (Figure 1A). The increase of
p27 was primarily observed during the early stage of lens cell484 Developmental Cell 35, 483–496, November 23, 2015 ª2015 Elsdifferentiation and after 8 days of culturing, the level of p27
was comparable to the vehicle control, consistent with the
period of exit of cell cycle and initiation of fiber cell differentiation.
There was no difference between the mRNA level of p27 in cells
expressing Cx50 or vehicle control at day 4 and day 8 of primary
lens cell culturing (Figure S1), suggesting that the increased p27
during lens differentiation was regulated at the protein, but not at
the mRNA level. Interestingly, p27 was barely detectable in the
lens epithelial cells, but was richly expressed in the lentoids,
where the differentiated fiber cells predominate (Figure 1B). To
determine if p27 is involved in the role of Cx50 in lens cell differ-
entiation, p27 was knocked down using siRNA. The stimulatory
effect of Cx50 on the differentiation indicated by increasedevier Inc.
numbers of lentoids (Figure 1C, middle) and expression of aqua-
porin 0 (AQP0), a marker for lens cell differentiation (Figure 1C,
left) was significantly attenuated. To further validate the role of
p27, we took advantage of a Skp2-resistant mutant of p27
(T187A). The comparable expression of p27 and p27(T187A)
was observed (Figure 1D, left). Compared to wild-type (WT)
p27, expression of p27(T187A) mutant further enhanced lens
cell differentiation evidenced by increased total lentoid numbers
(Figure 1D, middle) and expression of AQP0 (Figure 1D, right).
Co-expression of Cx50 did not further augment the effect
possibly due to the saturated level of p27 achieved since overex-
pression of Cx50 did not further enhance the level of p27 shown
by western blots (Figure 1D, left). These results suggest that
Cx50 increases the expression of p27, which is correlated with
the role of Cx50 in promoting lens cell differentiation and further
imply that lens cell differentiation is governed by cell-cycle exit.
Moreover, p27 functions as a downstream effector of Cx50 on
the lens cell differentiation.
Skp2 Mediates the Effect of Cx50 on Lens Cell
Differentiation and Exit of Cell Cycle
The level of p27 is known to be directly regulated by Skp2, a ma-
jor component of the E3 ligase complex, SCFSkp2, responsible
for p27 ubiquitination and subsequent degradation in the nu-
cleus (Carrano et al., 1999; Nakayama et al., 2004). Because
upregulation of p27 as shown in Figure 1 in differentiated lens fi-
bers occurs at the protein level (Figure 1A and Figure S1) and
Skp2-resistant mutant of p27, p27(T187A) further enhanced
lens cell differentiation (Figure 1D), it would be interesting to
test if Skp2 is involved in the process of lens differentiation.
RCAS(A) retrovirus containing either of the two shRNAs against
different regions of Skp2 was used to knock down Skp2 in pri-
mary lens cells. The expression of Skp2 mRNA was reduced
by 70%–80% by either of these two shRNAs compared to
the vehicle control (Figure S2A). Skp2 knockdown by two
shRNAs, as expected, increased p27 protein level, but had no ef-
fect on Cx50 and b-actin (Figure S2B). Knocking down Skp2 by
either of the two shRNAs in lens primary cells significantly
elevated the formation of lentoids (Figure 2A, left), and the
expression of AQP0 (Figure 2A, right). The degree of the increase
by Skp2 knockdown by either shRNA in lens cell differentiation is
comparable, if not greater than that of Cx50 overexpression. Co-
expressing Cx50 and either Skp2 shRNA further enhanced the
primary lens cell differentiation. We have previously shown that
unlike WT Cx50, the Cx50(V362E) mutant has a minimal effect
on lens differentiation (Shi et al., 2010). Expression of the
Cx50(V362E) mutant, unlikeWT Cx50, failed to augment lens dif-
ferentiation induced by either Skp2 shRNA (Figure 2B). These re-
sults suggest that Skp2 is likely involved in the role of Cx50 in
promoting lens differentiation.
To further confirm the role of Skp2, recombinant RCAS(A)
retrovirus containing Skp2 or a E3 ubiquitin ligase-impaired, F-
domain deleted mutant, Skp2(DF) tagged with FLAGwas gener-
ated and expressed alone or co-expressed with Cx50 in chick
lens primary culture. Overexpression of exogenous Skp2 signif-
icantly attenuated the differentiation of lens cells by suppressing
lentoid formation (Figure 2C, left) and AQP0 expression (Fig-
ure 2C, right). However, this effect was not observed with the
overexpression of Skp2(DF), suggesting that this effect ofDevelopmeSkp2 is likely to be mediated by F-domain of Skp2. In addition,
co-expression of Skp2, but not Skp2(DF), significantly sup-
pressed the stimulatory effect of Cx50 on lens cell differentia-
tion, showing similar levels of lentoids and AQP0 as compared
to the RCAS(A) vehicle control group. This inhibitory effect of
Skp2 on Cx50-induced enhancement of lens cell differentiation
was not observed when Skp2 was co-expressed with the
Cx50(V362E) mutant (Figure 2D). Western blots showed compa-
rable expression levels of Cx50, Skp2, and mutants (Figure 2E).
Together, these data support the role of p27/Skp2 in lens cell
differentiation, a functional interaction between Skp2 and
Cx50 and the involvement of F-domain of Skp2 and Val-362 of
Cx50.
We then determined the functional relationship between Cx50
and Skp2 in cell proliferation and cell-cycle control. CEF cells
were infected with various recombinant retroviruses containing
Cx50, Cx46, Cx43, and/or Skp2 and a bromodeoxyuridine
(BrdU) incorporation assay was performed (Figure 3A). Cx50,
but not the other two lens connexins, significantly decreased
the proliferation rate. In contrast, Skp2 dramatically increased
cell proliferation, but this effect was significantly compromised
when co-expressed with Cx50 (Figure 3A). The V362E mutation
attenuated the ability of Cx50 to suppress cell proliferation and
the stimulatory effect of Skp2 on cell proliferation (Figure 3B).
Conversely, reduction of Skp2 by Skp2 shRNA decreased the
proliferation rates of CEF cells. Interestingly, co-expression of
Cx50 and either of the two Skp2 shRNAs did not lead to a further
reduction of cell proliferation (Figure 3C). The effects of Cx50 and
Skp2 on cell proliferation coincided with their effects on lens cell
differentiation, which further suggests that lens cell differentiation
and proliferation were coupled. To determine if the effect of Cx50
on cell proliferation is mediated by p27, we knocked down p27
with siRNA. p27 siRNA significantly increased cell proliferation
and further blocked the inhibitory effect of Cx50 (Figure 3D).
As a prominent marker for cells entering S phase, Skp2 expres-
sion level increases whereas p27 decreases (Nakayama et al.,
2004). To determine whether Cx50 affects cell-cycle progression
and at which stage(s) the effect occurs, wemonitored the cell-cy-
cle progression in CEF cells expressing RCAS(A) (vehicle), Cx50,
or Cx50(V362E) (Figure 3E). CEF cells were synchronized at G0/
G1 phase by serum starvation for 72 hr, and the cell-cycle arrest
was released by adding fresh medium containing normal serum.
Cell populations in different cycle phases were quantified by flow
cytometry analysis (FACS). The results showed that incubation in
serum-free media for 72 hr arrested most of cells at the G0/G1
phase (80%–90% cells in G0/G1). During 0–12 hr after releasing
from G0/G1 arrest, there was no significant difference between
cells expressing vehicle, Cx50, or Cx50(V362E) mutant. However,
16 hr after G0/G1 arrest, more than 50% of CEF cells expressing
vehicle or Cx50(V362E) mutant entered S phase in contrast to
only 15% of cells expressing Cx50 (Figure 3E). The results sug-
gest that Cx50 significantly delayed cell-cycle progression after
release from the G0/G1 phase, indicating that Cx50 induced a
cell-cycle arrest at the G1/S boundary, thereby decreasing cell
proliferation.
Cx50-CT Directly Interacts with Skp2-N Terminus
Similar protein sequences were identified between cyclin
A-NT and Cx50-CT (Figure S3). Cyclin A has been shown tontal Cell 35, 483–496, November 23, 2015 ª2015 Elsevier Inc. 485
Figure 2. Skp2, but Not Skp2(DF), Attenuates the Stimulatory Effect of Cx50 on Lens Cell Differentiation
(A) Inhibition of Skp2 stimulates cell differentiation, and expression of Cx50 augments this effect in primary lens cells. Lentoid formation was quantified during
3–8 days of culturing (left) and the level of AQP0 was shown (right)..
(B) Expression of mutant Cx50(V362E) fails to augment the stimulatory effect on lens cell differentiation by inhibition of Skp2.
(C) Overexpression of Skp2, but not Skp2(DF), inhibits lens cell differentiation, but expression of Cx50 reverses this effect.
(D) Cx50(V362E) fails to stimulate lens cell differentiation suppressed by Skp2, while Skp2(DF) failed to suppress lens cell differentiation.
(E) Comparable levels of Cx50, Cx50(V362E), Skp2, and Skp2(DF) were expressed alone or co-expressed in lens primary cells. All the data were presented as the
means ± SEM (n = 3). *p < 0.05; **p < 0.01; ***p < 0.001, compared to vehicle control group, unless indicated otherwise.
See also Figure S2.directly interact with Skp2 (Ji et al., 2006). We hypothesized
that Cx50 could interact with Skp2 in a similar manner as cy-
clin A. The association between Cx50 and Skp2 was shown by
a co-immunoprecipitation (coIP) assay. Skp2 and/or Cx50
were expressed in CEF cells (Figure 4A, left). CoIP using an
antibody against the Cx50 intracellular loop domain showed
that Skp2 was only precipitated in cells co-expressing Skp2
and Cx50, but not in cells expressing Skp2 or Cx50 alone
(Figure 4A, right). The coIP result was also confirmed with
non-FLAG-tagged Cx50 and Skp2 to exclude the potential is-
sues associated with FLAG tags on both proteins (Figure 5E).
Significantly less Skp2 was co-immunoprecipitated in cells
expressing Cx50(V362E) mutant (Figure 5E), suggesting that
Val-362 plays an important role in the interaction between486 Developmental Cell 35, 483–496, November 23, 2015 ª2015 ElsCx50 and Skp2. CoIP assay was performed to determine stoi-
chiometry of the interaction by using fixed amount of Cx50-
expressing CEF cell lysate with various amount of Skp2-
expressing CEF cell lysate. The molar ratio of the Cx50 to
Skp2 was estimated to be approximately two to three based
on the saturated levels of the binding between these two pro-
teins (Figure S4).
To identify the interaction motifs on Cx50 and Skp2, based
on the known interaction between cyclin A-NT and Skp2-NT (Ji
et al., 2006), two GST-tagged Skp2 fusion proteins were gener-
ated by fusing fragments of Skp2 (amino acids [aa] 1–70 or aa
1–120) with GST (Figure 4B, upper). A pull-down assay with
Cx50-CT-GST fusion protein-conjugated beads showed that
Cx50 was associated with Skp2(1–120), but not Skp2(1–70) orevier Inc.
Figure 3. Skp2-p27 Pathway Mediates Inhibitory Effects of Cx50 on Cell Proliferation and Cell-Cycle Progression
(A–D) The proliferation of CEF cells expressing Cx50 (WT or V362E mutant), Cx43, Cx46, or/and Skp2 (or Skp2 shRNAs) via retroviral infection or p27 siRNA was
measured by BrdU labeling assay.
(A) Cx50 inhibits cell proliferation, but not Cx43 or Cx46, and Skp2 suppresses the inhibitory effect by Cx50.
(B) Cx50(V362E) mutant does not inhibit the stimulatory effect by overexpressing Skp2.
(C) Inhibition of Skp2 by either of the two Skp2 shRNAs suppresses the cellular proliferation and augments the inhibitory effect of Cx50.
(D) p27 siRNA increased cell proliferation and attenuated the inhibitory effect of Cx50.
(E) Cx50 delays cell-cycle progression, but Cx50(V362E) mutant does not. CEF cells were labeled with PI and analyzed with FACS.
All data were presented as the means ± SEM (n = 3–5), *p < 0.05; **p < 0.01; ***p < 0.001, compared to vehicle control group, unless marked otherwise. N.S., not
significant.GST (Figure 4B, lower). This result suggests that the region
around aa 70–120 of Skp2 was important for its interaction with
Cx50. The reverse pull-down assay was performed using various
sizes of Cx50 CT-GST to define the interactive domain on Cx50-
CT. GST-tagged Cx50-CT fusion proteins were generated
including Cx50-F2 (aa 273–420) containing a full-length CT
domain; Cx50-F1 (aa 307–389), a shorter fragment of the CT
domain; and Cx50-Fs (aa 369–400), the shortest fragment of
CT domain, lacking the PEST domain and Val-362 residue (Fig-
ure 4C, upper). Skp2 was pulled down by both Cx50 F1 and F2,
but not by Cx50 Fs. A very low level of Skp2 was detected in F1
and F2 containing the V362E mutation (Figure 4C, lower). This
result suggests that Skp2 interacted with the CT region (aa 307–
369) of Cx50 and Val-362 plays a critical role in this interaction.
To determine the direct interaction between specific domains
of Skp2 and Cx50, beads conjugated with His-tagged Skp2-NT
(aa 1–120) (Figure 4D, upper) were incubated with Cx50 F1-GST,
Fs-GST, or GST. Only the F1 fragment, but not Fs and GST, was
able to interact with His-tagged Skp2-NT (aa 1–120). This result
demonstrates the direct interaction between specific regions of
Skp2-NT and Cx50-CT.
To test if Val-362 is directly involved in this interaction, a binding
competition assay was performed (Figure 4E). With increasingDevelopmeconcentration, the peptide derived from Cx50-CT (sequence:
AEEEEEQEEEQQAPQEEPGVKKAEEEVVSDEVEGPY; aa 336–
370) reduced the interaction between Skp2 NT (1–120 aa) and
Cx50 F1, while the same peptide with the mutation V362E had
no such effect. These data support that Val-362 residue plays a
critical role in the interaction between Cx50 and Skp2.
A computer simulation method was used to predict the inter-
action interface by a molecular docking software MolDock
(Thomsen and Christensen, 2006). The hypothetical structure
of Cx50-CT contains four hypothetical helical loops (Shi et al.,
2010). The fragment, Skp2 (aa 70–120), was predicted to
be located in a helical loop (PDB: 1FQV). The docking
program predicted that four cavities in Cx50-CT are potential
interacting sites with other proteins, primarily locating within
or between the third and fourth helical loop regions
(labeled in blue, Figure 4F). The model with the highest pre-
dictive score suggested that Skp2-NT was very likely to
interact with one of these cavities and to form three hydrogen
bonds at predicated sites of Glu361, Glu359, and Lys356 on
Cx50-CT and a short fragment on Skp2-NT (GVSWDE, aa
115–120). Two additional hydrogen bonds were identified
at the other region of helical loops, which were far away
from the cavity regions (Figure 4G). Based on the modeling,ntal Cell 35, 483–496, November 23, 2015 ª2015 Elsevier Inc. 487
Figure 4. Cx50-CT Directly Interacts with Skp2-NT, whereas the Mutation on V362E Weakens the Interaction
(A) Cx50 associates with Skp2.
(B–D) Cx50-CT directly interacts with Skp2-NT and Cx50(V362E) mutant weakens the interaction. Two GST fusion proteins was generated, Skp2(1-70)-GST and
Skp2(1-120)-GST (B, upper). Pull-down assay was conducted with FLAG-tagged Cx50 and Skp2(1-70)-GST or Skp2(1-120)-GST fusion protein (B, lower). Three
GST fusion proteins of Cx50-CTs were used for protein pull-down assay (C, upper) with FLAG-tagged Skp2 (C, lower). 9xHis-Skp2-NT was incubated with GST,
Fs-GST, or F1-GST-beads (D).
(E) Peptide competition assay by pre-incubating His-Skp2-NT-beads with WT or V362E mutant Cx50-CT, prior to incubation with Cx50-F1-GST.
(F) The hypothetical 3D structure model showing the interaction between Cx50-CT and Skp2-NT. The possible interacting cavities on Cx50-CT were labeled in
blue.
(G) Amplified interaction interface between Cx50-CT and Skp2-NT. Amino acids residues on Cx50 involved in this interaction were labeled in light blue boxes and
Val-362 in a pink box.
See also Figure S3.Val-362 was located in the interaction interface of Cx50 and
Skp2. Given the fact that the V362E mutation de-stabilizes
the a-helical structures of Cx50-CT, we postulated that the
mutation on Val-362 would alter the interaction interface and
consequently disrupt the interaction between Cx50 and Skp2.
This simulation modeling of the interaction between Cx50 and
Skp2 suggests that the Cx50 helical loop motif containing
Val-362 is capable of making energetically favorable interac-
tions with the Skp2 molecule, which is consistent with our
experimental data.
Cx50 Retains Skp2 in the Cytosol and Prevents Its
Nuclear Localization
Skp2, as the substrate recognition subunit of the SCF complex,
forms the SCFSkp2 complex in the cytosol and directs it into the
nucleus (Lisztwan et al., 1998); therefore, Skp2 is predominantly488 Developmental Cell 35, 483–496, November 23, 2015 ª2015 Elslocalized in the nucleus. Consistently, when expressed alone in
CEF cells, Skp2 was primarily localized in the nucleus, whereas
Cx50 was located in the cytosol (Figure 5A, upper). Interest-
ingly, when co-expressed with Skp2 and Cx50, Skp2 predom-
inantly localized to the cytosol, while nuclear expression of
Skp2 was barely detectable (Figure 5A, middle). Cx50 and
Skp2 were partially co-localized with each other in the cytosol
(indicated by white arrows). However, when co-expressed
with Skp2 and the Cx50(V362E) mutant, Skp2 remained in the
nucleus while Cx50(V362E) was located in the cytosol. To
further confirm the localization of Skp2, we separated the frac-
tions enriched in nuclear (indicated by nuclear marker, PARP-1)
and cytosol (cytosolic marker, GAPDH) portions of cells ex-
pressing Skp2 alone, both Skp2 and Cx50, or Skp2 and
Cx50(V362E) mutant. Skp2 was only detected in the cytosolic
fraction of cells expressing both Skp2 and Cx50, but not inevier Inc.
Figure 5. Interaction with Cx50 Retains Skp2 in the Cytosol and Hinders the NLS of Skp2 and Cx50
(A) Cx50 and Skp2 are partially co-localized in the cytosol. Co-localization was indicated by white arrow. Scale bar represents 20 mm.
(B) Skp2 is enriched in cytosolic fractions of the cells expressing WT Cx50, but not vehicle or Cx50(V362E) mutant.
(C) Skp2 is predominantly localized in nucleus in the lens bow region of Cx50 KOmice. Scale bar represents 20 mm. The fluorescence images are derived from the
bow regions as indicated in red frames (cartoon, lower right). The magnified, overlay image of double labeling with Cx50 and FLAG-Skp2 antibodies of WT lens is
shown in lower left (from the images overlaid in white square box, and the co-localization is indicated by white arrows).
(D) Skp2(DNLS) is located in the cytosol of CEF cells. Scale bar represents 20 mm.
(E) Cx50 fails to interact with Skp2(DNLS), and V362E mutation disrupts the interaction between Cx50 and Skp2. *Indicates a non-specific band.
See also Figure 4.the cytosol of control cells or cells expressing Cx50(V362E)
(Figure 5B). The absence of Skp2 in nuclear fractions further
confirms the redistribution of Skp2 from the nucleus to the
cytosol in the presence of Cx50. To confirm the role of Cx50
in preventing nuclear localization of Skp2, we examined the dis-
tribution pattern of Skp2 in lenses of WT and Cx50 KO mice.
The dual-immunofluorescence of mouse lenses showed that
at the lens bow region close to the lens equator (indicated by
the frame, Figure 5C, lower right, lens cartoon), the area with
the active process of lens cell differentiation, Skp2 was found
to locate predominately in the nuclei of lens cells in Cx50 KO
mice; however, no apparent nuclear localization was observed
in WT control mice (Figure 5C). Moreover, Cx50 and Skp2 are
partially co-localized as indicated by white arrows (Figure 5C,
enlarged image, lower left). This in vivo result further validatedDevelopmethe in vitro observation regarding the role of Cx50 in retaining
Skp2 in the cytosol.
Skp2 as a nuclear protein possesses a nuclear localization
signal (NLS) sequence (aa 88–100) predicted by PredictNLS (Co-
kol et al., 2000). This sequence resides within the interactive
domain (aa 70–120) of Skp2 with Cx50. It is possible that the
interaction with Cx50 would block the accessibility of the NLS
domain, thereby preventing the nuclear translocation of Skp2.
To test this hypothesis, we generated the recombinant RCAS(A)
retrovirus containing Skp2(DNLS) (Skp2 lacking NLS sequence).
Unlike WT Skp2, Skp2(DNLS) primarily localized to the cytosol
(Figure 5D) and lost the ability of Skp2 to interact with Cx50 (Fig-
ure 5E). The results indicate that blocking of the NLS domain
because of the interactionwith Cx50 is a likelymechanism in pre-
venting the nuclear localization of Skp2.ntal Cell 35, 483–496, November 23, 2015 ª2015 Elsevier Inc. 489
Figure 6. Cx50 De-stabilizes Skp2 via Auto-ubiquitination during Cell-Cycle Progression and Blocks the Association among Skp2, Importin-
7, and Cdh1
(A) Cx50 de-stabilizes Skp2 at the mitotic phase. The protein level was quantified and normalized to 0 hr.
(B) Cx50 delays the increased expression of Skp2 during cell-cycle progression. The level of protein was quantified and normalized to 0 hr.
(C) The reduction of Skp2 by Cx50 is not affected by p27 siRNA.
(D) Cx50 increases ubiquitination level of Skp2. The protein expression levels were examined with western blotting (lower).
(E) Cx50 has no effect on the association of Skp2 with Skp1, but disrupts Skp1/2 interaction with importin-7 and Cdh1.
(F) Cx50 C terminus increases auto-ubiquitination of Skp2 in vitro. SCFSkp2 complex was used for in vitro ubiquitination assay with isolated GST-fusion containing
WT or V362Emutant of Cx50 C terminus or GST. The specificity of the assay was validated containing all assay-required materials except Mg-ATP, ubiquitin (Ub)
or E1/E2 enzymes, respectively.
See also Figure S5.Cx50 Destabilizes Skp2 and Stabilizes p27 through
Protein Ubiquitination
Expression levels ofSkp2are coordinatedwithprogression of the
cell cycle starting at very low levels in the early G1 phase,
increasing in the late G1 phase and reaching the maximal value
in the S and G2/M phases (Michel and Xiong, 1998; Lisztwan
et al., 1998). To test if cytosolic retention had any impact on pro-
tein stability of Skp2, we determined protein turnover of Skp2
in CEF cells treated with cycloheximide (CHX). CHX, an inhibitor490 Developmental Cell 35, 483–496, November 23, 2015 ª2015 Elsof protein biosynthesis in eukaryotic organisms was used to
determine the rate of protein turnover (Ennis and Lubin, 1964;
Yin et al., 2008) and induce cell-cycle arrest at G1/S phases
(Adolph et al., 1993; Liu et al., 2010). During a 4-hr treatment
with CHX, co-expression with Cx50 led to a faster degradation
of Skp2 as compared to cells expressing Skp2 alone or co-
expressing with the Cx50(V362E) mutant (Figure 6A). Similar re-
sults were obtained in mouse cells. In the presence of CHX,
expression of mouse Cx50 in mouse embryonic fibroblastevier Inc.
(MEF) cells greatly accelerated the degradation of endogenous
Skp2 as compared to vehicle controls (Figure S5). We further
determined the impact of Cx50 on Skp2 expression level during
the cell cycle (Figure 6B). The increase of Skp2 from S to G2/M
transition (from 8% S phase cells at 10 hr time point to 30% S
phase cells at 14 hr) was significantly suppressed by Cx50 as
compared to that of Skp2 in cells without Cx50 expression. To
assess if the effect of Cx50 on Skp2 is preserved with reduced
progression of cell cycle in the presence of Cx50, we depleted
p27 with siRNA. As compared with the scrambled RNA control,
deletion of p27 by siRNA had no effect on the reduction of
Skp2 by Cx50 (Figure 6C), suggesting that the effect of Cx50
onSkp2 is not influencedbyp27and the reduced rateof cell cycle
is due to Cx50. Like most cell-cycle regulators, Skp2 levels are
regulated by ubiquitination and subsequent proteasome degra-
dation (Wirbelauer et al., 2000; Bashir et al., 2004; Wei et al.,
2004). The level of Skp2 ubiquitination in CEF cells expressing
Cx50 or the Cx50(V362E) mutant was examined. Co-expression
of Cx50 dramatically increased the level of ubiquitinated Skp2
(Figure 6D), which was consistent with the effects of Cx50 on
destabilization of Skp2 anddecreased expression of Skp2during
cell-cycle progression. The primary E3 ligase for Skp2 is APCcdh1
complex, which normally functions in the nucleus. To test if Skp2
undergoes another cytosolic ubiquitin-related degradation, spe-
cifically auto-ubiquitination by the SCFSkp2 complex (Wirbelauer
et al., 2000), we examined that if the SCFSkp2 complex would still
remain intact in the presence of Cx50. The coIP experiments
demonstrated that indeed, Skp1, another important component
of SCFSkp2 complex, was present in the Skp2 and Cx50 complex
(Figure6E), suggesting thatCx50 is unlikely todisturb the integrity
of the SCFSkp2 complex. To test the possibility that Cx50 inter-
fereswith theassociation ofSkp2with importin-7, aproteinmedi-
ating nuclear transport of Skp2, coIPwasperformed and the data
showed the absence of importin-7 in coIPwith Cx50, but not with
vehicle or Cx50(V362E)-expressing cells (Figure 6E). Cdh1 is a
major component for Cdh1-anaphase-promoting complex
(APC), which mediates degradation of Skp2 in the nucleus.
CoIP showed the lack of association between SCFSkp2 complex
and Cdh1 in the presence of Cx50 (Figure 6E). This data further
support cytosolic localization of Skp2 with the expression of
Cx50. To further exploit thedirect role ofCx50onauto-ubiquitina-
tion of Skp2, in vitro ubiquitination assay was performed. The
SCFSkp2 complex (containing Skp1/ROC/Cul1 components)
was isolated from CEF cells by immunoprecipitation with FLAG
antibody as shown in Figure 6E and was incubated with GST
fusion proteins containing WT, V362 mutant of Cx50 C-terminal
domains or GST protein. Cx50 C-terminal domain (GST-
Cx50(CT)) increased the extent of Skp2 ubiquitination and this in-
crease was not observed with GST fusion protein containing
Cx50V362Emutant (Figure 6F). Thepresence of the components
of SCFSkp2 complex, Skp1, Rock1, and Cul1 was also detected
with coIP.Moreover, the ubiquitination product was not detected
in the reaction lacking ATP, ubiquitin, or E1/E2 enzymes. This
result suggests a direct effect of Cx50 on promoting auto-ubiqui-
tination of Skp2, likely through the direct interaction between
Cx50 via the involvement of V362 residue and Skp2.
The level of p27 protein during the cell cycle is regulated
through the ubiquitin-proteasome pathway (Pagano et al.,
1995; Hengst and Reed, 1996). Skp2 as an E3 ligase specificallyDevelopmeregulates p27 ubiquitination during cell-cycle progression. The
expression level and stability of p27 are inversely correlated to
the level of Skp2 during cell-cycle progression; at a very high
level in the G0 and early G1 phase, but decreasing in the late
G1 phase and reaching the lowest level at the later S and G2/M
phases (Besson et al., 2006). We showed that Cx50 delayed
cell-cycle transition from the G1 to S phase. It is likely that the
delay in cell-cycle progression by Cx50 was caused by the
increased level of p27 due to cytosolic retention and destabiliza-
tion of Skp2 induced by Cx50. We synchronized the cells at G0/
G1 phase with serum starvation, and treated cells with CHX for
the indicated times (0–6 hr) (Figure 7A). The expression of
Cx50 decreased the turnover of p27 as compared to non-Cx50
expressed controls. At the 10 hr time point when cells started
to enter S phase (8.6% cells at S phase at 10 hr time point;
30%Sphase cells at 12 hr), therewas an increase of p27 expres-
sion. However, in cells expressing Cx50, the increase of p27 ap-
peared at the 14 hr time point (12.4% cells at S phase; 26.5% S
phase cells at 18 hr), indicating a delay of entering the S phase
(Figure 7B). The expression of Cx50 enriched percentage of
the cells at G1 phase. However, knocking down p27 significantly
reduced the cells at G1 phase. This reduction was slightly, but
significantly attenuated by the co-expression of Cx50, although
the extent of attenuation was lower than that with p27 (Figure 7C,
right). This modest attenuation is likely due to incomplete p27
knockdown during initial state of cell-cycle arrest. Consistent
with a reduced level of Skp2, the amount of ubiquitinated p27
proteins was much less in cells expressing Cx50 compared to
cells without Cx50 or expressing the Cx50(V362E) mutant
(Figure 7D), suggesting that Cx50 increases the stabilization of
p27 by decreasing its ubiquitination/degradation through the
reduction of overall level and cytosolic retention of Skp2. Due
to its predominant localization in the cytosol in the presence of
Cx50, Skp2 degradation is not mediated by the APC complex
as evidenced by the absence of the association between Skp2
and Cdh1 (Figure 6D).
The lens size of Cx50 knockout is significantly smaller than that
of theWT animal (White et al., 1998; Rong et al., 2002). The levels
of p27 (Figure 7E) and p57 (Figure 7F) were significantly
decreased in the lens of Cx50 knockout mice. Lens cell differen-
tiation occurs in the bow region close to lens equator. Immuno-
fluorescence data showed reduced signals of p57 in the differen-
tiating lens fibers in Cx50 knockout lenses (Figure 7F, lower).
Together, these data suggest that Cx50 plays an important
role in regulating lens cell differentiation via its direct effect on
Skp2 and consequently, the levels of p27/p57.
DISCUSSION
Accumulating data have shown channel-independent roles of
connexins in cellular events including cell growth, proliferation
and differentiation, tumorigenicity, and wound healing (for
review, see Jiang and Gu, 2005; Zhou and Jiang, 2014). Howev-
er, the molecular mechanism underlying non-conventional func-
tions of connexins remained largely unexplored. Connexin fam-
ily proteins have a relatively conserved membrane topology,
with similar NT and extracellular loop domain sequences,
whereas the cytoplasmic CT domain are diverse (Goodenough
and Paul, 2009). Increasing evidence indicates that the CTntal Cell 35, 483–496, November 23, 2015 ª2015 Elsevier Inc. 491
Figure 7. Stabilization of p27 by Cx50 during the Cell Cycle and Reduction of p27/p57 in Cx50-Deficient Lens
(A) Cx50 stabilizes p27 at G0/G1 phase. The protein levels were normalized to 0 hr.
(B) Cx50 increases the expression level of p27 during cell-cycle progression. The expression level of protein was normalized to 0 hr of RCAS(A) vehicle control.
(C) Knocking down p27 promotes the cell cycle that is arrested by Cx50. The cell population was determined by FACS analysis with PI staining.
(legend continued on next page)
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domains of connexin proteins contribute to channel-indepen-
dent functions. Previous studies show that analogous to full-
length Cx43, the CT domain of Cx43 by itself that does not
form functional gap junction can inhibit tumor cell growth (Zhang
et al., 2003a). We have previously shown that the role of Cx50 in
promoting lens cell differentiation is independent of its function
in forming gap junctions or hemichannels (Banks et al., 2007,
2009; Gu et al., 2003), and the CT domain and Val-362 residue
are primarily responsible for this function (Banks et al., 2007;
Shi et al., 2010). Unveiling the sequential similarity between
Cx50 and cyclin A inspired us to examine the relationship be-
tween Cx50 and the cyclin A-binding partner, Skp2. Here, we
demonstrated the direct interaction between Cx50 and Skp2,
and identified interactive domains on both proteins. Su et al.
showed that Skp2 siRNA inhibits rabbit lens epithelial cell prolif-
eration (Su et al., 2010) . Our study revealed how Skp2 is regu-
lated in the lens epithelial-fiber differentiation. We used two
different shRNAs to knock down Skp2. Reduction of Skp2
expression accelerates, whereas overexpression delays differ-
entiation of lens cells, which is inversely correlated with prolifer-
ation of lens epithelial cells. Cx50 rescues the lens cell differen-
tiation suppressed by Skp2, but further augments the
differentiation induced by Skp2 shRNAs.
Interestingly, the related sequences of Cx50 and cyclin A are
similar, but the level of homology is relatively low (Figure S3A).
By comparing the sequence, we found that cyclin A-interacting
motif on Skp2 (Ji et al., 2006) (Figure S3B, underlined) falls into
the 70–120 aa region of chick Skp2. Therefore, consistent with
the known interaction between Skp2 and cyclin A, our data sup-
ported that this region of Skp2 mediates its interaction with
Cx50. Although Cx50 and cyclin A appear to bind to a similar re-
gion on Skp2; however, this is unlikely a competitive binding
since unlike Cx50, the interaction with cyclin A primarily occurs
in the nucleus. We have previously shown that the V362E muta-
tion compromises the ability of Cx50 in promoting lens cell differ-
entiation (Shi et al., 2010). Here, we show that Val-362 is located
in the interaction interface of Cx50 and Skp2. The mutation on
Val-362 (V362E) uncouples the interaction between Cx50 and
Skp2. In contrast to WT Cx50, the expression of this mutant
cannot attenuate the inhibitory effect on differentiation by
Skp2. This evidence suggests that direct physical interaction
with Skp2 is essential for the role of Cx50 in promoting lens
cell differentiation.
The NT region (aa 70–120) of Skp2, the identified Cx50-
interactive domain, has been shown to be involved in multiple
cellular functions. Cyclin A binds to Skp2 at this region (Ji
et al., 2006). This region, however, is different from the active
domain of Skp2 E3 ligase in the SCFSkp2 complex involved
in mediating p27 ubiquitination. Mutations on this cyclin A(D) Cx50 decreases ubiquitination level of p27. The protein levels were examined
(E) Decreased levels of p27 in Cx50-knockout lens. Lens lysates from 3-day-old
(F) Decreased levels of p57 in the bow region of Cx50-knockout lens. Lens lysa
b-actin antibody (upper left) and quantified (upper right). The frozen tissue sect
rescence-labeled (lower left) and quantified (lower right). Scale bar represents 50
(G) Schematic model illustrates the interaction and mechanistic roles of Cx50 and
cytosol, leading to cytoplasmic retention of Skp2, thereby preventing it from trans
of p27/p57 in nucleus and less degradation of p27/p57. Right: the increased p27
promotion of lens cell differentiation.
Developmebinding region attenuate the ability of Skp2 to counter cell-cy-
cle arrest through the p53/p21-mediated checkpoint (Ji et al.,
2007). Cyclin A is activated during the S to G2/M transition and
Skp2-cyclin A interaction is important for protecting cyclin A
from binding to p27, since the association with p27 blocks
the ability of cyclin A in promoting cell-cycle progression (Ji
et al., 2007). Our study suggests that connexin, an atypical
cell-cycle regulator, plays a critical role in controlling this pro-
cess. The interaction with Cx50 in the cytosol consequently
reduces the amount of Skp2 in the nucleus and thus its inter-
action with cyclin A, leading to increased binding of p27 with
cyclin A and consequently, the inhibition of cyclin A and sup-
pression of cell-cycle progression. Interestingly, APC/Ccdh1
complex binds to Skp2 through the similar N-terminal domain
(aa 46–94 in human Skp2) (Bashir et al., 2004; Wei et al.,
2004), which is corresponding to the region on chick Skp2
at aa 77–121. That explains why Cdh1 dissociated with
Skp2 in the presence of Cx50, further supporting our observa-
tion of translocation of Skp2 with expression of Cx50.
Sequestering Skp2 in the cytosol, thus preventing the transfer
to its functional location in nucleus, switches the cells from highly
proliferative to a differentiating state. Skp2 is a major component
of SCFSkp2 E3 complex catalyzing the ubiquitination of proteins.
This complex is located in the cytoplasm until Skp2 is expressed
in late G1 phase and inclusion of Skp2 helps the complex
SCFSkp2 migrate into the nucleus (Lisztwan et al., 1998). This
complex promotes the ubiquitination of selected proteins,
including cyclin E/cyclin D, p27, and p57. We found that Cx50
was capable of retaining Skp2 in the cytosol. Moreover, in addi-
tion to Skp2, we also detected the presence of Skp1/Roc1/Cul1
in the coIP of Cx50, which supported the notion that intact
SCFSkp2 complex is likely to be retained in the cytosol as a result
of the interaction between Cx50 and Skp2. Skp2 normally re-
sides in the nuclei; however, cytosolic localization of Skp2 has
been reported (Drobnjak et al., 2003; Li et al., 2004; Lim et al.,
2002; Radke et al., 2005; Lin et al., 2009). The major question
is what causes normally nuclear localized Skp2 to reside in cyto-
plasm. Recent studies suggest that subcellular localization of
Skp2 is regulated by protein phosphorylation (Gao et al., 2009;
Lin et al., 2009); however, this observation was not supported
by other studies (Bashir et al., 2010; Boutonnet et al., 2010).
We showed that Skp2 is absent from the nucleus in the presence
of Cx50. Therefore, interactionwith Cx50 as demonstrated in this
study is likely an important mechanism for cytosolic retention of
Skp2.
We show that nuclear targeting of the NLS domain of Skp2
overlaps with the Cx50 interactive domain and deletion of NLS
inhibits Skp2 interaction with Cx50. Interaction with Cx50 may
hinder the NLS domain of Skp2, thereby preventing its nuclearby western blotting (lower).
WT and Cx50 knockout mice were immunoblotted (left) and quantified (right).
tes of 3-day old WT and Cx50 KO mice were immunoblotted with anti-p57 or
ions of 3-day-old lenses from WT or Cx50 knockout mice were immunofluo-
mm.
Skp2 in regulating lens cell differentiation. Left: Cx50 interacts with Skp2 in the
locating into nucleus. Reduced nuclear Skp2 leads to decreased ubiquitination
due to the retention of Skp2 in cytosol by Cx50 leads to cell-cycle arrest and
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translocation. Indeed, the interaction with Cx50 prevented the
association of Skp2 with importin-7, a critical mediator for
nuclear transport of Skp2. Another possibility is that the binding
of Skp2 to Cx50 may cause conformational change with
the exposure of other possible protein binding sites of Skp2,
such as the adjacent nuclear export signal (NES) domain (aa
127–135). Association with other protein(s) may further help
retain Skp2 in the cytoplasm; however, continuous association
with Cx50 at this stage may not be necessary. This may explain
that not all cytosolic Skp2 is co-localized with Cx50 in the
cytosol, although the exact mechanism requires further investi-
gation. Moreover, at lens bow region with an active process of
epithelial-fiber differentiation, Skp2 is expressed at the cytosol
of the WT mouse lens with minimal expression in nucleus, and
partially co-localized with Cx50. However, in Cx50 KO lens,
Skp2 is predominantly expressed in the nucleus of lens cells.
This in vivo observation strengthened the finding that Cx50
retains Skp2 in the cytosol.
Upregulation of Skp2 is a key step required for the passage of
cells from the G1 to S phase during the cell cycle (Nakayama
et al., 2004). We showed that interaction with Cx50 significantly
reduced this upregulation, which subsequently delays cell-cy-
cle progression, and this reduction was mediated by protein
ubiquitination. Indeed, more Skp2 protein was modified by
ubiquitination in the presence of Cx50. One of the possible ex-
planations is that the protein conformational change of Skp2
because of its interaction with Cx50 may reveal the sites suit-
able for modification by ubiquitin. Skp2 is targeted for ubiquiti-
nation and degradation by APCcdh1 (Bashir et al., 2004; Wei
et al., 2004); however, the APCcdh1 complex is primarily local-
ized in the nuclei of cells so it is unlikely that cytosolic Skp2
can be accessed by the APCcdh1 complex. Consistently, we
showed that Skp2 failed to interact with Cdh1 only in Cx50,
but not in vehicle or Cx50(V362E)-expressing cells. Skp2 un-
dergoes auto-ubiquitination in the SCFSkp2 complex (Wirbela-
uer et al., 2000) and interaction with Cx50 may promote this re-
action. Indeed, our in vitro ubiquitination assay with isolated
SCFskp2 complex showed that C terminus of Cx50 directly
increased auto-ubiquitination Skp2 and such increase was not
observed in V362E mutant that disrupts the interaction between
Cx50 and Skp2. Our data also showed that Skp1 was still asso-
ciated with Skp2 whereas Skp2 formed the complex with Cx50,
implying that binding with Cx50 is unlikely to disrupt the forma-
tion of SCFSkp2 complex. Previous studies have shown that the
ubiquitin-proteasome pathway is active during lens cell prolifer-
ation and differentiation (Guo et al., 2004, 2006; Gira˜o et al.,
2005; Imai et al., 2010), although the key molecules responsible
for this pathway have not been reported. Skp2 could be one of
the key molecules involved in protein ubiquitination in the lens.
Consistent with the downregulation of Skp2, we observed that
protein turnover of p27 was significantly delayed by Cx50, lead-
ing to the augmentation of overall p27 level throughout the cell
cycle. The protein level of p27 is also tightly regulated by the
ubiquitination system, primarily through E3 ligase Skp2 in the
nucleus (Nakayama et al., 2004). Kip1 ubiquitination-promoting
complex (KPC) is also reported to be responsible for the ubiqui-
tination of cytosolic p27 (Kamura et al., 2004), suggesting an
Skp2-independent, cell-cycle phase-specific ubiquitin-protea-
some pathway. Downregulation of Skp2 in the nucleus induced494 Developmental Cell 35, 483–496, November 23, 2015 ª2015 Elsby its interaction with Cx50 in cytosol, as expected, decreased
enzymatic activity of Skp2 leading to lesser ubiquitination and
more stabilization of p27. Therefore, elucidating how the inter-
action of Cx50 regulates the ubiquitination of Skp2 and the
possible involvement of SCFSkp2 complex will be a direction
for further investigation.
We observed the predominant expression of p27 in the
lentoids, where the differentiated fiber cells accumulated, but
not in proliferative epithelial cells. This expression pattern
matches the role of p27 in attenuating the progress of the cell
cycle. Furthermore, we showed that knocking down p27 by
siRNA attenuated the stimulatory effect of Cx50 on lens cell dif-
ferentiation and inhibitory effort on cell proliferation, suggesting
that p27 is a downstream effector of Cx50. The relationship be-
tween Skp2 and p27 was supported by the observation that the
expression of Skp2-resistant mutant p27(T187A) further
augmented lens cell differentiation. Interestingly, expression
of this mutant did not further enhance the effect of Cx50
because co-expression with Cx50 mutant did not increase the
total amount of p27 as compared to the expression of this
mutant alone. Previous studies have reported that p27 is pre-
sent around lens equator regions and p27/p57 are important
regulators in mouse lens development (Kase et al., 2005; Zhang
et al., 1998). We showed both p27 and p57 proteins were greatly
decreased in Cx50 KO mouse lens and this decrease is well
correlated with the reduction of lens size. Correspondingly,
the reduction of p57 protein is evident in the Cx50 KO around
bow region, a highly differentiating zone of the lens. Together,
the present study establishes physical and functional connec-
tions between the connexin molecule and core cell-cycle regu-
lators, and delineates a mechanism regarding connexin mole-
cules in orchestrating cell-cycle control, proliferation, and
differentiation.EXPERIMENTAL PROCEDURES
Cell-Cycle Synchronization and Flow Cytometric Analysis
To synchronize the cell at G1/S phase, CEF cells were plated at 30% conflu-
ency, treated with 2 mM thymidine for 18 hr, and followed by incubation with
fresh medium containing 10% FBS for 9 hr to release the cells back into cell
cycle. Second cell-cycle blockwas performed by treating with 2mM thymidine
for 17 hr. To synchronize the cells at G2/M phase, CEF cells at 30% conflu-
ency were treated with 2 mM thymidine for 24 hr and followed by the addition
of fresh medium and incubation for 3 hr to release cells back into the cell cycle,
followed by 100 ng/ml nocodazole for another 12 hr. For synchronizing cells at
G0/G1 phase, CEF cells at 30%–40% confluency were incubated with FBS-
free medium for 72 hr, and released into cell cycle by incubation with the
medium containing 10% FBS.
For FACS analysis, CEF cells were harvested in 0.25% trypsin solution, fixed
in cold 75% ethanol, and stored at 20C for 16 hr. Fixed cells were subse-
quently washed once with cold PBS, treated with RNase A (100 mg/ml) in
PBS and 50 mg/ml propidium iodide (PI) for 30 min in the dark. DNA content
of cells was quantified in a BD Biosciences FACS Calibur (UTHSCSA Flow Cy-
tometry Core) with 10,000 events for G0/G1 cell population using BD Biosci-
ences Cell Quest software, and the data were analyzed by FlowJo software.
Ubiquitination Assay
For in vivo assay, ubiquitin protein was expressed ectopically in cells by using
recombinant RCAS(A) retrovirus containing ubiquitin tagged with c-myc. CEF
cells were infected with the indicated recombinant retroviruses for 48 hr,
treated with 10 mM MG132 for 6 hr, and lysed in IP buffer. The cell extracts
were then incubated withmonoclonal anti-p27 antibody (1:2,500) or polyclonalevier Inc.
anti-FLAG antibody (for Skp2) (1:5,000) and protein G or A beads, respectively,
at 4C for 16 hr. The beadswere thenwashed three timeswith IP buffer and the
proteins were eluted with 50 ml non-reducing laemmli sample buffer before
SDS-PAGE and western blotting. The ubiquitinated proteins were depicted
by probing blots with c-myc antibody (1:5,000) (Invitrogen).
To assess in vitro ubiquitination in reconstituted system, SCFSkp2 complex
was immunoprecipitated with anti-FLAG M2 affinity gel (Sigma) from cell
lysate of FLAG-Skp2-expressing CEF cells. The precipitates were then
washed with IP buffer twice, PBS three times, and finally ubiquitination assay
buffer (5 mM Tris [pH 8], 0.5 mMMgCl2, 0.01% Tween-20 and 0.1 mM b-mer-
captoethanol) five times. Then, the precipitates were subjected to auto-ubiq-
uitination assay by using the VIVAbind Ub kit from VIVA Bioscience. Briefly,
the precipitates were mixed with E1, E2 mix (UbcH3, UbcH5b, UbcH5C
and Ubc13), ubiquitin, Mg-ATP, GST, GST-Cx50-CT, or GST-Cx50-
CT(V362E) fusion proteins, 103 ub assay buffer, and then incubated at
37C for 6 hr.
Statistical Analysis
All the data were analyzed using GraphPad Prism 5.04 software (GraphPad
Software). One-way ANOVA and Student-Newman Keul’s test were used for
more than two compared groups and paired Student’s t test was used for
comparison between two groups. Unless otherwise specified in the figure leg-
ends, the data are presented as the mean ± SEM of at least three determina-
tions. Asterisks indicate the degree of significant differences: *p < 0.05, **p <
0.01, ***p < 0.001.
Reagent information and other experimental procedures are included in the
Supplemental Experimental Procedures. Experiments related to animals were
approved by the Institutional Animal Care and Use Committee of UTHSCSA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2015.10.014.
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